US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist

9.470
-0.140-1.46%

Close Nov 22 16:00 ET

9.500
+0.030+0.32%

Post 17:41 ET

465.68MMarket Cap-9194P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-109.01%-5.2M

64.50%-4.42M

90.89%-1.02M

-1,013.28%-27M

-101.56%-854K

85.31%-2.49M

9.40%-12.44M

57.95%-11.22M

98.97%-2.43M

221.35%54.91M

Net income from continuing operations

-41.88%-12.7M

-5.65%-16.53M

47.19%-11.66M

40.54%-55.19M

40.31%-8.51M

42.32%-8.95M

31.36%-15.65M

45.14%-22.09M

64.98%-92.82M

75.34%-14.26M

Operating gains losses

-16,400.00%-163K

----

326.50%1.35M

-101.14%-1K

-99.97%1K

150.77%1.32M

113.74%29K

712.82%317K

--88K

Depreciation and amortization

-18.68%762K

5.95%979K

20.55%1.18M

-39.41%4.26M

-30.02%1.42M

-46.97%937K

-51.60%924K

-26.08%978K

-18.31%7.02M

58.20%2.03M

Deferred tax

--90K

---561K

---513K

--3.21M

--0

----

Other non cash items

3.45%630K

13.38%644K

14.36%629K

141.27%2.35M

13.27%623K

29.30%609K

129.65%568K

-70.57%550K

152.56%974K

2,300.00%550K

Change In working capital

74.57%-342K

145.86%2.69M

79.90%4.12M

-119.69%-8.34M

-105.73%-3.41M

91.17%-1.35M

-397.82%-5.87M

157.93%2.29M

207.08%42.35M

1,154.65%59.56M

-Change in receivables

-101.90%-2.55M

110.35%365K

-37.76%2.81M

74.67%-689K

84.39%-417K

22.45%-1.26M

-1,571.09%-3.53M

152.52%4.52M

-250.86%-2.72M

-4,073.44%-2.67M

-Change in prepaid assets

135.06%657K

176.21%724K

187.18%3.99M

-155.39%-4.45M

-290.93%-3.01M

54.30%-1.87M

-136.34%-950K

-82.52%1.39M

-38.22%8.03M

-73.55%1.58M

-Change in payables and accrued expense

4,482.43%6.78M

136.52%1.14M

3.69%-3.21M

58.16%-7.09M

-227.39%-786K

102.31%148K

-488.53%-3.12M

72.12%-3.34M

58.43%-16.94M

109.65%617K

-Change in other current assets

-89.86%155K

-150.67%-226K

-102.58%-30K

81.19%-1.55M

-20.20%-4.68M

202.21%1.53M

115.73%446K

116,000.00%1.16M

-746.30%-8.23M

-11,558.82%-3.9M

-Change in other current liabilities

-1,508.40%-1.68M

-196.96%-1.24M

15.13%-1.22M

393.48%4.55M

27,041.18%4.58M

107.45%119K

-27.71%1.28M

15.99%-1.43M

-60.52%-1.55M

99.22%-17K

-Change in other working capital

----

38,760.00%1.93M

29,783.33%1.78M

-98.61%886K

-98.59%903K

0.00%-6K

97.08%-5K

33.33%-6K

647.20%63.76M

2,228.70%63.95M

Cash from discontinued investing activities

-761.12%-184.57M

-6,455.40%-178.97M

Operating cash flow

-109.01%-5.2M

64.50%-4.42M

90.89%-1.02M

85.56%-27M

99.31%-854K

88.77%-2.49M

15.57%-12.44M

56.96%-11.22M

10.04%-186.99M

-192.35%-124.06M

Investing cash flow

Cash flow from continuing investing activities

-82,752.38%-17.4M

-127.44%-3.03M

139.56%17.03M

-155.54%-32.7M

-101.73%-677K

99.89%-21K

47.00%11.05M

-234.84%-43.05M

-52.71%58.88M

261.80%39.16M

Net PPE purchase and sale

28.57%-15K

-107.98%-36K

87.50%-91K

-175.35%-975K

-154.51%-677K

-136.84%-21K

569.79%451K

-145.53%-728K

138.06%1.29M

40.09%-266K

Net investment purchase and sale

---17.38M

-128.27%-3M

140.45%17.12M

-157.81%-31.72M

--0

39.22%10.6M

-239.55%-42.32M

-57.10%54.87M

249.90%39.43M

Net other investing changes

----

--2.71M

--0

Cash from discontinued investing activities

Investing cash flow

-82,752.38%-17.4M

-127.44%-3.03M

139.56%17.03M

-102.83%-32.7M

-101.73%-677K

-100.00%-21K

47.00%11.05M

-234.84%-43.05M

826.96%1.15B

261.80%39.16M

Financing cash flow

Cash flow from continuing financing activities

98.82%-372K

99.95%-44K

96.95%-1.72M

73.07%-198.93M

13.71%-30.61M

95.53%-31.4M

-57,728.57%-80.68M

-3,783.98%-56.24M

-904.07%-738.62M

-23,906.71%-35.47M

Net issuance payments of debt

----

--0

----

-5,786.33%-631.6M

--0

Net common stock issuance

98.82%-372K

99.48%-419K

96.95%-1.72M

-50.86%-199.55M

13.98%-30.78M

66.84%-31.4M

-23,279.25%-81.13M

-3,783.98%-56.24M

-233.46%-132.28M

-7,765.05%-35.79M

Proceeds from stock option exercised by employees

--0

----

-22.94%618K

-44.90%173K

-200.00%-1K

----

-76.89%802K

-48.01%314K

Net other financing activities

----

--24.46M

--0

Cash from discontinued financing activities

-20.19M

Financing cash flow

98.82%-372K

99.95%-44K

96.95%-1.72M

73.78%-198.93M

13.71%-30.61M

95.65%-31.4M

-57,728.57%-80.68M

-3,783.98%-56.24M

-926.05%-758.81M

-23,906.71%-35.47M

Net cash flow

Beginning cash position

-55.67%47.18M

-71.00%54.67M

-86.50%40.38M

229.32%299.01M

-82.71%72.52M

20.77%106.43M

98.00%188.5M

229.32%299.01M

10.32%90.8M

243.03%419.37M

Current changes in cash

32.27%-22.97M

90.87%-7.49M

112.93%14.29M

-224.21%-258.63M

73.30%-32.14M

-110.24%-33.91M

-1,059.99%-82.07M

-2,607.53%-110.51M

2,350.71%208.21M

-282.59%-120.37M

End cash Position

-66.61%24.21M

-55.67%47.18M

-71.00%54.67M

-86.50%40.38M

-82.71%72.52M

20.77%106.43M

98.00%188.5M

229.32%299.01M

Free cash flow

-107.86%-5.21M

66.50%-4.45M

90.85%-1.11M

84.28%-29.49M

98.77%-1.53M

88.65%-2.51M

10.48%-13.29M

53.80%-12.16M

11.22%-187.56M

-189.94%-124.32M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-109.01%-5.2M	64.50%-4.42M	90.89%-1.02M	-1,013.28%-27M	-101.56%-854K	85.31%-2.49M	9.40%-12.44M	57.95%-11.22M	98.97%-2.43M	221.35%54.91M
Net income from continuing operations	-41.88%-12.7M	-5.65%-16.53M	47.19%-11.66M	40.54%-55.19M	40.31%-8.51M	42.32%-8.95M	31.36%-15.65M	45.14%-22.09M	64.98%-92.82M	75.34%-14.26M
Operating gains losses	-16,400.00%-163K	----	----	326.50%1.35M	-101.14%-1K	-99.97%1K	150.77%1.32M	113.74%29K	712.82%317K	--88K
Depreciation and amortization	-18.68%762K	5.95%979K	20.55%1.18M	-39.41%4.26M	-30.02%1.42M	-46.97%937K	-51.60%924K	-26.08%978K	-18.31%7.02M	58.20%2.03M
Deferred tax	--90K	---561K	---513K	--3.21M	--3.21M	--0	--0	--0	--0	----
Other non cash items	3.45%630K	13.38%644K	14.36%629K	141.27%2.35M	13.27%623K	29.30%609K	129.65%568K	-70.57%550K	152.56%974K	2,300.00%550K
Change In working capital	74.57%-342K	145.86%2.69M	79.90%4.12M	-119.69%-8.34M	-105.73%-3.41M	91.17%-1.35M	-397.82%-5.87M	157.93%2.29M	207.08%42.35M	1,154.65%59.56M
-Change in receivables	-101.90%-2.55M	110.35%365K	-37.76%2.81M	74.67%-689K	84.39%-417K	22.45%-1.26M	-1,571.09%-3.53M	152.52%4.52M	-250.86%-2.72M	-4,073.44%-2.67M
-Change in prepaid assets	135.06%657K	176.21%724K	187.18%3.99M	-155.39%-4.45M	-290.93%-3.01M	54.30%-1.87M	-136.34%-950K	-82.52%1.39M	-38.22%8.03M	-73.55%1.58M
-Change in payables and accrued expense	4,482.43%6.78M	136.52%1.14M	3.69%-3.21M	58.16%-7.09M	-227.39%-786K	102.31%148K	-488.53%-3.12M	72.12%-3.34M	58.43%-16.94M	109.65%617K
-Change in other current assets	-89.86%155K	-150.67%-226K	-102.58%-30K	81.19%-1.55M	-20.20%-4.68M	202.21%1.53M	115.73%446K	116,000.00%1.16M	-746.30%-8.23M	-11,558.82%-3.9M
-Change in other current liabilities	-1,508.40%-1.68M	-196.96%-1.24M	15.13%-1.22M	393.48%4.55M	27,041.18%4.58M	107.45%119K	-27.71%1.28M	15.99%-1.43M	-60.52%-1.55M	99.22%-17K
-Change in other working capital	----	38,760.00%1.93M	29,783.33%1.78M	-98.61%886K	-98.59%903K	0.00%-6K	97.08%-5K	33.33%-6K	647.20%63.76M	2,228.70%63.95M
Cash from discontinued investing activities				0					-761.12%-184.57M	-6,455.40%-178.97M
Operating cash flow	-109.01%-5.2M	64.50%-4.42M	90.89%-1.02M	85.56%-27M	99.31%-854K	88.77%-2.49M	15.57%-12.44M	56.96%-11.22M	10.04%-186.99M	-192.35%-124.06M
Investing cash flow
Cash flow from continuing investing activities	-82,752.38%-17.4M	-127.44%-3.03M	139.56%17.03M	-155.54%-32.7M	-101.73%-677K	99.89%-21K	47.00%11.05M	-234.84%-43.05M	-52.71%58.88M	261.80%39.16M
Net PPE purchase and sale	28.57%-15K	-107.98%-36K	87.50%-91K	-175.35%-975K	-154.51%-677K	-136.84%-21K	569.79%451K	-145.53%-728K	138.06%1.29M	40.09%-266K
Net investment purchase and sale	---17.38M	-128.27%-3M	140.45%17.12M	-157.81%-31.72M	--0	--0	39.22%10.6M	-239.55%-42.32M	-57.10%54.87M	249.90%39.43M
Net other investing changes	----	----	----	----	----	----	----	----	--2.71M	--0
Cash from discontinued investing activities
Investing cash flow	-82,752.38%-17.4M	-127.44%-3.03M	139.56%17.03M	-102.83%-32.7M	-101.73%-677K	-100.00%-21K	47.00%11.05M	-234.84%-43.05M	826.96%1.15B	261.80%39.16M
Financing cash flow
Cash flow from continuing financing activities	98.82%-372K	99.95%-44K	96.95%-1.72M	73.07%-198.93M	13.71%-30.61M	95.53%-31.4M	-57,728.57%-80.68M	-3,783.98%-56.24M	-904.07%-738.62M	-23,906.71%-35.47M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	-5,786.33%-631.6M	--0
Net common stock issuance	98.82%-372K	99.48%-419K	96.95%-1.72M	-50.86%-199.55M	13.98%-30.78M	66.84%-31.4M	-23,279.25%-81.13M	-3,783.98%-56.24M	-233.46%-132.28M	-7,765.05%-35.79M
Proceeds from stock option exercised by employees	--0	----	----	-22.94%618K	-44.90%173K	-200.00%-1K	----	----	-76.89%802K	-48.01%314K
Net other financing activities	----	----	----	----	----	----	----	----	--24.46M	--0
Cash from discontinued financing activities				0					-20.19M	0
Financing cash flow	98.82%-372K	99.95%-44K	96.95%-1.72M	73.78%-198.93M	13.71%-30.61M	95.65%-31.4M	-57,728.57%-80.68M	-3,783.98%-56.24M	-926.05%-758.81M	-23,906.71%-35.47M
Net cash flow
Beginning cash position	-55.67%47.18M	-71.00%54.67M	-86.50%40.38M	229.32%299.01M	-82.71%72.52M	20.77%106.43M	98.00%188.5M	229.32%299.01M	10.32%90.8M	243.03%419.37M
Current changes in cash	32.27%-22.97M	90.87%-7.49M	112.93%14.29M	-224.21%-258.63M	73.30%-32.14M	-110.24%-33.91M	-1,059.99%-82.07M	-2,607.53%-110.51M	2,350.71%208.21M	-282.59%-120.37M
End cash Position	-66.61%24.21M	-55.67%47.18M	-71.00%54.67M	-86.50%40.38M	-86.50%40.38M	-82.71%72.52M	20.77%106.43M	98.00%188.5M	229.32%299.01M	229.32%299.01M
Free cash flow	-107.86%-5.21M	66.50%-4.45M	90.85%-1.11M	84.28%-29.49M	98.77%-1.53M	88.65%-2.51M	10.48%-13.29M	53.80%-12.16M	11.22%-187.56M	-189.94%-124.32M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data